Cue Biopharma, Inc. CUE
4.15 USD -0.35 (-7.78%)
Regular-session close
4.20 +0.05 +1.20%
After hours · Nov 20, 7:39 PM ET
4.05 Day range 4.90
2.83 52-week range 37.84
- YTD
- -54.64%
- 1 year
- -74.43%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 27.47M | 9.29M | 5.49M | 1.25M | 14.94M | |
| 27.47M | 9.29M | 5.49M | 1.25M | 14.94M | |
| -26.55M | -41.50M | -52.15M | -53.23M | -43.71M | |
| -26.60M | -40.67M | -50.73M | -53.01M | -44.16M | |
| -8.40 | -21.60 | -33.30 | -44.70 | -42.30 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 27.29M | 22.61M | 48.66M | 51.76M | 64.52M | |
| 42.21M | 32.19M | 61.53M | 91.28M | 83.40M | |
| 15.78M | 14.69M | 24.45M | 25.60M | 17.91M | |
| 4.20M | 8.88M | 14.70M | 19.32M | 10.05M | |
| 26.43M | 17.50M | 37.09M | 65.68M | 65.49M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -21.69M | -36.33M | -39.96M | -41.81M | -38.84M | |
| 75.00K | 32.00K | 25.00M | -24.61M | 9.11M | |
| 26.29M | 10.24M | 11.86M | 53.66M | 19.23M | |
| -137.00K | 32.00K | 2.00K | -165.00K | -891.49K | |
| 4.68M | -26.05M | -3.10M | -12.76M | -10.50M |
